The 60-second version of Alkosign Limited — what it does, how it earns, and who it competes with, before any of the numbers below.
| Metric | FY23 | FY24 | FY25 | FY26 | 3Y CAGR |
|---|---|---|---|---|---|
| Revenue | ₹21 Cr | ₹36 Cr | ₹29 Cr | ₹27 Cr | +7.7% |
| EBITDA | ₹3 Cr | ₹5 Cr | ₹7 Cr | ₹4 Cr | +12.1% |
| EBITDA Margin | 14.4% | 12.8% | 23.7% | 16.2% | — |
| PAT (Net Profit) | -₹0 Cr | ₹1 Cr | ₹4 Cr | -₹5 Cr | — |
| EPS | ₹-0.56 | ₹0.81 | ₹3.49 | — | — |
| ROE | -3.7% | 2.7% | 11.4% | -16.9% | — |
| ROCE | 5.8% | 6.1% | 12.0% | 6.3% | — |
| Total Debt | ₹20 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr | -13.5% |
| Free Cash Flow | -₹7 Cr | -₹2 Cr | -₹1 Cr | -₹0 Cr | — |
| Company | P/E | ROE |
|---|---|---|
| LARSEN & TOUBRO LTD. | 30.1x | 15.2% |
| SIEMENS LTD | 88.8x | 10.5% |
| ABB INDIA LIMITED | 92.6x | 19.1% |
A reasonable business at a reasonable price. Nothing here is alarming and nothing is compelling, which usually means the decision rests on things this data cannot see — the industry's direction, management's intent, and what else is available to you. 3 high-severity red flags sit above this conclusion and should be read first.